Translating the best science to improve human health is at our core. We focus both on trials that help define the role of specific molecular imaging agents, and trials using imaging to improve and optimize novel therapeutics.
The imaging trials that we are leading use positron emission tomography or near infrared optical imaging. Four overarching themes are improved disease detection, margin delineation, in situ characterization across all disease sites and their evolution over time, and non-invasive assessment of response to targeted therapy. In each trial, we collaborate with disease specific experts to ensure the approach for each study directly addresses current major unmet clinical needs or helps to answer important questions regarding disease pathophysiology.
Please click here to see select publications in this area.